Photrexa cross-linking kit 6ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCHX2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,270
Award facts
- Contract value 100% obligated
- $12,269.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $12,269.80 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of PHOTREXA Cross-Linking Kit 6ML. The contract, issued as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by February 25, 2026, with performance to be executed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group will serve as the sole contractor with no identified subcontractor involvement on this award.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion acquisition vehicle established to support recurring pharmaceutical and medical consumable needs across the Department of Defense's global healthcare operations. The PPV-G GEN V represents DLA's broader $30.3 billion pharmaceutical sourcing strategy, structured with a 30-month base period and three 30-month option periods extending through December 31, 2036. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for military healthcare facilities worldwide.
Quick answers
Who was awarded contract SPE2DR26FCHX2?
SPE2DR26FCHX2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26FCHX2 worth?
The government has obligated $12,270 on SPE2DR26FCHX2.
Is contract SPE2DR26FCHX2 an order under another contract?
Yes. SPE2DR26FCHX2 is a delivery order under SPE2DR25D9113, an indefinite delivery contract.
Was contract SPE2DR26FCHX2 competed?
The extent of competition for SPE2DR26FCHX2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award